key: cord-0292574-l4okqh5j
authors: Kim, Juewon; Jo, Yunju; Cho, Donghyun; Ryu, Dongryeol
title: L-threonine mediated DAF-16/HSF-1 activation inhibits ferroptosis and increases healthspan
date: 2022-01-25
journal: bioRxiv
DOI: 10.1101/2022.01.24.477604
sha: 27cf0c1b1c4a65f5e5a982a5d92a295866588e24
doc_id: 292574
cord_uid: l4okqh5j

The pathways that impact longevity in the wake of dietary restriction (DR) pathway remain still ill-defined. Most studies have focused on nutrient limitation and perturbations of energy metabolism to explain the beneficial effects of DR. We showed that the essential amino acid L-threonine was elevated in Caenorhabditis elegans under DR, and that L-threonine supplementation increased its healthspan. To elucidate the underlying mechanism, we conducted metabolic and transcriptomic profiling using LC-MS/MS and RNA-seq analyses in worms that were fed with RNAi to induce loss of function of key candidate mediators and evaluated healthspan. L-threonine supplementation and loss-of-threonine dehydrogenase, which govern L-threonine metabolism, increased the healthspan of C. elegans by attenuating ferroptosis in a ferritin-dependent manner. Tran-scriptomic analysis of C. elegans supplemented with L-threonine showed that FTN-1 encoding ferritin was elevated, implying FTN-1 is an essential mediator of longevity promotion through L-threonine. Organismal ferritin levels were positively correlated with chronological aging and L-thre-onine supplementation further increased ferritin levels, which protected against age-associated ferroptosis through the DAF-16 and HSF-1 pathways. Our investigation uncovered the role of a distinct and universal metabolite, L-threonine, in DR-mediated improvement in organismal healthspan, suggesting it could be an effective intervention for preventing senescence progression and age-induced ferroptosis.

Reduced food intake without malnutrition can attenuate age-associated disorders in invertebrate model organisms and mammals, including humans 2 1,2 . Dietary restriction (DR), defined as the coordinated reduction of intake of all dietary ingredients except vitamins and minerals, extends the 3 lifespan of aging model organisms and improves most health phenotypes during aging 3 . Because of diminished calorie intake during DR, most 4 metabolic processes and metabolic intermediates are reduced, and this decreased metabolic network can induce efficient metabolic activity in 5 many organisms 4,5 . Thus, it is reasonable to postulate that high metabolic efficiency improves many of the physiological and molecular changes 6 involved in age-related autonomic dysfunctions. Therefore, we speculated that increased metabolites during DR interventions might be involved 7 in the attenuation of age-associated decline. To test this hypothesis, we screened for elevated metabolites in DR and a DR-related mutant in 8 Caenorhabditis elegans. We identified several metabolic intermediates whose concentration is altered, of which the most increased was the essen-9 tial amino acid L-threonine. 10 Nutrient amino acid imbalance has been investigated with regard of its impact on physiological processes, health and the regulation of aging. 11 Previous studies reported that imbalanced amino acid levels may contribute to the incidence of adverse effects on aging in a rat model and suggested 12 that reduced intake of a particular protein and amino acids may have essential roles in explaining the benefits of DR. However, the medical 13 literature and mass media often suggest that high protein supplements, particularly those rich in essential amino acids, and having branched-chain 14 amino acids, can overcome age-related sarcopenia, obesity, frailty, and mortality. Recent studies have been in line with this opinion, showing that 15 specific amino acids could positively affect the organismal lifespan and health factors. For example, glycine extended the lifespan of C. elegans 16 in a methionine cycle-dependent manner, and glycine supplementation extended the lifespan of male and female mice 6,7 . Additionally, branched-17 chain amino acids induced a central neuroendocrine response, thereby extending healthspan 8 , facilitating survival, and supporting cardiac and 18 skeletal muscle mitochondrial biogenesis in middle-aged mice 9 . These studies supported the theory that regulation of dietary amino acid levels 19 can enhance healthspan in organisms and provided evidence in support of the further investigation of the effects of characteristic amino acids on 20 senescence and late-life diseases 10, 11 . 21 In the case of L-threonine, it was reported that threonine metabolism was a crucial factor for stem cell maintenance and renewal by influencing 22 histone methylation [12] [13] [14] [15] . Moreover, as a major component of mucins, threonine plays a conclusive role in the maintenance of mucosal integrity, 23 barrier constitution, and eventually immune function regulation [16] [17] [18] [19] . Recently, the effects of threonine on age-associated metabolic pathways, lipid 24 metabolism 20 , and methylglyoxal (MGO)-mediated proteohormesis 21 were investigated. In this study, it was revealed that impaired threonine 25 catabolism promoted C. elegans healthspan by activating a highly reactive compound in the MGO-mediated proteasome pathway. Despite these 26 initial indications on the importance of threonine, its roles and metabolism in aging remain largely unknown. 27 If the effect of threonine on aging is conserved across metazoa and beyond, lifespan regulation by altered threonine metabolism should also be 28 conserved in the commonly used aging model, C. elegans. We here uncovered the role of threonine and its catabolic enzyme threonine dehydro-29 genase (TDH) inhibition in C. elegans lifespan and healthspan regulation and suggest that it is mediated by ferritin-mediated ferroptosis. The use 30 of defined diets with specific changes in amino acids composition in C. elegans could hence provide an experimental system with which to examine 31 the consequences of amino acid impairment and its effects on aging and other physiological functions. To gain perspective into the longevity and change in endogenous metabolites, we sorted dietary restriction (DR)-associated metabolites for their 3 effects on lifespan using the C. elegans model. Using a LC-MS/MS metabolic profiling, we detected several metabolic pathways that were signif-4 icantly altered in worm subjected to the DR and DR-mimic mutant, eat-2 model (Fig. 1a, Supplementary Data 1) . According to previous studies 5 1,3 , DR lowered almost all metabolic processes, because of limited calorie and nutrient intake. In contrast, we discovered that several metabolites 6 were increased under DR and in the eat-2 mutants compared to the wild type, N2 strain (Fig. 1b) . Among the metabolites that were increased, 7 including ribose 5-phosphate, creatinine, and glutathione, several of these metabolites were already recognized to affect longevity, including NAD + 8 22,23 and metabolites involved lipid metabolism 24 . Most interestingly, we found that the most elevated amino acid, threonine, delayed the aging 9 process and extended the lifespan of nematodes by 18% (Fig. 1c, Extended Data Fig. 1a, b) . The dose-response changes in mean lifespan upon 10 threonine exposure showed that low concentrations are enhancing longevity, with 200 μM threonine exhibiting the maximal lifespan extension 11 (Fig. 1d) ; 200 μM was used for subsequent assays. Threonine not only elongated lifespan, it also improved health-related parameters, average 12 speed, and coordinated body movement (Fig. 1e) , and reduced age-related triglyceride (TG) content ( Fig. 1f) 25 . Moreover, unlike many other 13 lifespan-extending compounds, there was no significant alteration in body size, pharyngeal pumping reflected calorie intake or brood size with 14 bacterial proliferation in the presence of threonine (Extended Data Fig. 1c-f ). Importantly, threonine enhanced the levels of major reactive oxygen 15 species (ROS) defence enzymes, superoxide dismutase (SOD), catalase activity, and resistance against acute oxidative stress with no induction of 16 thermotolerance (Figure 1g -I, Extended Data Fig. 1g) . Collectively, the DR-related metabolite threonine increased the healthspan by the induction 17 of antioxidative protection. It was furthermore interesting to note that previous studies on anti-aging compounds and metabolites, which reported 18 DR-mimic activity, including syringaresinol 26 , metformin 27 , and α-ketoglutarate 28 , also increased the threonine content in C. elegans (Fig. 1j) .

This indicates that threonine may act as a key amino acid in the DR-mediated longevity or metabolite for healthspan extension. Threonine was downregulated during aging and reduced catabolism related to DR 22 Based on the threonine metabolic pathway (KEGG_cel00260 and wormflux_c00188), we attempted to search for age-related changes of metabolic 23 enzymes and metabolites involving threonine (Fig. 2a) . We observed an age-dependent decline of threonine content (Fig. 2b) . Furthermore, DR 24 and also eat-2 animals exhibited decreased glycine and homoserine, which are precursors of threonine synthesis, and increased threonine without 25 conversion (Fig. 1b, 2c) . According to the Venn analysis based on public datasets, threonine metabolic enzymes, R102.4, threonine dehydrogenase 26 (TDH)/F08F3.4, and threonine deaminase/K01C8.1 were located in the intersection of differentially expressed genes (DEG) in the DR treatment 27 (GSE119485, padj < 0.05 in edgeR, Deseq2) 29 and the eat-2 worm DEG (GSE146412, padj < 0.05 in edgeR, Deseq2) 30 (Fig. 2d, Supplementary   28 Data 2). In the DR and eat-2 mutant, threonine-producing enzyme R102.4 expression was upregulated (Fig. 2e) , and the expression of threonine 29 catabolic enzyme F08F3.4 was downregulated (Fig. 2f ). Compared to long-lived worms, R102.4 expression was diminished in Day 5 nematodes 30 (Fig. 2h) , and F08F3.4 expression increased with age (Fig. 2i) . Under both conditions, the expression level of K01C8.1 did not change (Fig. 2g,   31 j). Increased production (R102.4), together with reduced catabolism (TDH/F08F3.4) of threonine, caused an increase in threonine abundance, 32 which potentially acted as longevity metabolites in C. elegans. Based on increased threonine levels, we applied RNA interference (RNAi) against tdh/F08F3.4 (siTDH) to N2 nematodes. We attained a mean 3 lifespan extension by 36.1% under the suppression of tdh/F08F3.4 expression (Fig. 2k, Extended Data Fig. 2a-c) . With the concomitant increased 4 amount of threonine (Fig. 2l) , siTDH stimulated locomotion (Fig. 2m) without alteration of physical body size, pumping rate, or progeny (Fig. 2n,   5 Extended Data Fig. 2d, e) . Additionally, similar to the threonine treatment condition, siTDH lowered TG contents (Fig. 2o) and improved antiox-6 idative defence (Fig. 2p-r) with no difference in resistance against thermal stress or bacterial growth (Extended Data Fig. 2f, g) . We next determined 7 whether blocking threonine generation affected aging parameters. The expression of the threonine-elaborating R102.4 enzyme was increased in 8 DR with eat-2 mutants and decreased in early-adult Day 5 worms (Fig. 2e, h) . We used R102.4 RNAi to inhibit threonine production. In contrast 9 to the observations for increased threonine (Fig. 1c -I, 2k-r), R102.4 RNAi shortened lifespan by 16.8% and reduced threonine (Extended Data Fig.   10 3a-e), further supporting threonine's regulatory action in the modulation of healthspan-related factors (Extended Data Fig. 3f -o). Impairment of 11 threonine metabolism by two different enzyme RNAi clones had adverse effects on lifespan in wild-type worms. Large amounts of threonine 12 occurred in long-lived C. elegans compared to the wild-type N2 nematodes and upregulated threonine contents induced healthspan prolongation, 13 suggesting that threonine itself enhances longevity, rather than its metabolites or precursors.

Threonine-mediated longevity depends on transcriptional oxidative stress-response factors DAF-16 and HSF-1 16 To determine the molecular mechanisms of the longevity effects of threonine, we performed RNA sequencing (RNA-seq) on nematodes exposed 17 to tdh/F08F3.4 RNAi for 5 d. We found 2,171 and 2,110 DEGs, respectively, which were upregulated and downregulated in comparison with 18 control RNAi (Fig. 3a) . With these remarkable changes in the transcriptome (Fig. 3b-c) , impaired tdh/F08F3.4 expression resulted in a metabolic 19 shift and alterations in senescence-regulatory pathways (Extended Data Fig. 4a ). All DEGs were combined, and using clustered expression profiles 20 for DEGs of DR and eat-2 worms compared to those of the wild type nematodes, we identified 23 upregulated and 13 downregulated genes 21 (Extended Data Fig. 4b , c). Focusing on the transcription factors of these DEGs and given the distinguished role of lifespan, we next tested whether 22 tdh/F08F3.4 has an epistatic interaction with DR, insulin/IGF-1, or stress-response regulators. Similar to the results for increased threonine and 23 decreased tdh/F08F3.4 levels in DR and eat-2 mutant (Fig. 1b, 2f) , siTDH and threonine application failed to further extend a lifespan of eat-24 2(ad465), which was different from N2 nematodes (Fig. 3d , Extended Data Fig. 4d -e, 5a-c). Interestingly, threonine catabolism impairment, or 25 threonine itself, interacted with daf-16, although its upstream transcription factor daf-2 did not ( Fig. 3e-f , Extended Data Fig. 4f-i) . This require-26 ment of daf-16 was specific because the lifespan of the even longer-lived insulin/IGF-1 receptor daf-2 mutant worms was further prolonged by 27 siTDH and threonine (Extended Data Fig. 5d-i) . Lastly, and according to a previous study with another threonine catabolic enzyme, glycine-C-28 acetyltransferase (GCAT) 21 , transcriptional stress-response regulator HSF-1 was also considered. The higher antioxidative enzyme activity and 29 oxidative stress resistance in threonine-treated animals suggested that threonine-mediated longevity may involve a similar context to that initiated 30 by stress stimulation. Furthermore, we confirmed that lifespan extension effects of both siTDH and threonine intervention were fully negated in 31 hsf-1(sy441) worms, which lacked the transactivation domain of the protein (Fig. 3g , Extended Data Fig. 4j -k, 5j-l). These findings demonstrated 32 epistatic interplay of threonine with daf-16 and hsf-1. In addition we confirmed that the nuclear translocation and increased expression of daf-1 16::gfp or hsf-1::gfp was intensely stimulated by tdh/F08F3.4 RNAi and additional threonine ( Fig. 3h-k) . 4 Based on these results, we selected six and two commonly up-and downregulated genes, respectively, which are transcribed by the transcription 5 factor DAF-16 or HSF-1, from the intersecting genes of tdh/F08F3.4 RNAi, DR, and eat-2 worms (Supplementary Data 3). All of these genes To determine the significance of FTN-1 to threonine-related longevity, we measured ftn-1 expression with physiological aging and in N2 worms 14 fed with tdh/F08F3.4 RNAi. As previously reported 31 , ftn-1 expression increased with age, but more importantly, its expression was further 15 elevated by the reduced expression of tdh/F08F3.4, especially at early adult stages ( Fig. 4g-h) . Thus, FTN-1 is required for the longevity advantage 16 of threonine. Given the interaction of ftn-1 expression with several genes, we exposed DR and eat-2 worms to the target gene RNAi, with control 17 RNAi serving as control. Although von Hipple-Lindau protein 1 (vhl-1), hypoxia-inducible transcription factor (hif-1), and prolyl hydroxylase egl-18 9 had no effect on ftn-1 expression, daf-16 and hsf-1 did affect elevated ftn-1 expression in DR and eat-2 worms, compared with the wild-type 19 nematodes (Extended Data Fig. 7a, b) . This may have occurred because of the specific regulation of ftn-1 in the threonine-mediated longevity 20 condition. Because ftn-1 expression is modulated by oxygen concentration, ftn-1 was regulated differently under normoxia, hypoxia, and hyperoxia 26 We next estimated whether iron contents might contribute to the long-lived phenotype. Similar to humans, C. elegans FTN-1 is induced by iron, 27 and accumulated reactive ferrous iron results in a non-apoptotic form of cell death, ferroptosis 32 . Quantifying the rate of ferrous iron (Fe 2+ , redox-28 active) / ferric iron (Fe 3+ , stable) concentrations following tdh/F08F3.4 RNAi or threonine also indicated a global diminution in organismal age-29 dependent ferroptosis (Fig. 4i, Extended Data Fig. 7f ). Decreased levels of ferrous iron may result from expended iron retention of FTN-1 and 30 result in inactivating ferroptosis. Moreover, this redox-active iron ratio (Fe 2+ / Fe 3+ ) was also dependent on daf-16 and hsf-1, similar to the regulation 31 of ftn-1 expression in DR or eat-2 nematodes (Extended Data Fig. 7g, h) . In the ferroptosis pathway, ferrous iron accumulates over the adult 32 lifetime of C. elegans 33 and exists as abundant reactive ferrous iron, which could generate massive damage through ROS, eventually inducing 33 ferroptosis and shortening the lifespan 34,35 . Hence, with the changes accruing during physiological aging, we detected in worms fed with 1 tdh/F08F3.4 RNAi or with reduced threonine an associated increase in ROS levels in whole nematode lysates, particularly during the late adult 2 stage (Fig. 4j , Extended Data Fig. 7i ). Additionally, we confirmed that the absence of daf-16 or hsf-1 failed to reduce ROS levels in DR and eat-2 3 worms, analogous to ftn-1 expression (Extended Data Fig. 8a-c) . As a substrate for the main regulator of ferroptosis glutathione peroxidase 4 4 (GPX4), glutathione (GSH) deficiency is coupled to ferrous iron accumulation in nematodes, and both occur to irritate cells leading to ferroptosis 5 33 . To systematically examine this, we determined whole GSH levels in worm lysates after tdh/F08F3.4 RNAi or threonine feeding at time points 6 during aging. With the age-response decline in GSH levels, threonine increasing interventions prevented GSH depletion (Fig. 4k , Extended Data 7 Fig. 7j) and increased the GSH level in DR and eat-2 worms, which was modulated by daf-16 or hsf-1 as assayed by the target gene RNAi 8 (Extended Data Fig. 8d-f ). Redox-active iron-dependent lipoxygenases and iron-catalysed peroxyl radical-mediated autoxidation could induce 9 lipid peroxidation, which executed ferroptosis 36 . We examined the toxic lipid peroxidation end-product malondialdehyde (MDA) to assay the 10 ferroptosis level 37 , tdh/F08F3.4 RNAi or threonine feeding reduced MDA levels in an age-dependent manner (Fig. 4l , Extended Data Fig. 7k ).

Similarly, the MDA level was lowered dependent on daf-16 or hsf-1 in DR and eat-2 nematodes (Extended Data Fig. 8g -i).

This, together with the results summarized above, raised the hypothesis that increasing threonine interventions attenuate compromised ferritin 13 capacity, inhibiting redox-active iron-mediated ferroptosis. To test this hypothesis, we determined the inhibitory effects of threonine elevation 14 treatment against ferroptosis stimulated by introducing ftn-1/C54F6.14 RNAi. As expected, with recovery of ftn-1 expressions ( Fig. 8j , k). When restoring the cellular GSH level by threonine interventions, we measured the highly 23 reactive by-product of glycolysis, MGO, with its scavenger, GSH. MGO is one of the representative cell-permeant precursors of advanced glycation 24 end-products (AGEs), which are associated with several age-related diseases. The MGO/GSH ratio was lowered with manipulations that increased 25 threonine levels; indicating, it was beneficial for longevity (Extended Data Fig. 8l-n) . Furthermore, the MGO/GSH ratio increased with aging and 26 long-lived DR and eat-2 worms showed a greatly decreased MGO/GSH ratio and a concordantly increased lifespan (Extended Data Fig. 8o-p) .

In the current study, we focused on threonine as a commonly increased metabolite in DR-mediated long-lived worms. Blocking threonine dehy-28 drogenase or supplementation with threonine itself lead to increased organismal threonine content. Increased threonine content leads through a 29 DAF-16 and HSF-1 dependent mechanism to the activation of FTN-1 and the antioxidant system, which attenuates ferroptosis, and mediates We specified commonly increased metabolites that may affect longevity in DR-mediated long-lived animals through a metabolomics approach.

Among the macronutrients, we identified threonine as most increased amino acid, despite previous studies showing that limitation of proteins or 3 amino acids is the most forceful single molecular restriction beneficially impacting on longevity and age-associated diseases 8,41 . Besides its role 4 in protein metabolism, threonine is also impacting on organismal maintenance processes, such as the synthesis of immune proteins and production 5 of intestinal mucus layers 19,42,43 . According to whole-genome sequencing analysis of semi-supercentenarians in Italy, glycine, serine, and threonine 6 metabolism were identified as the top-tier pathways involved in longevity 44 . Furthermore, a recent multi-omics study in mice revealed that the 7 threonine pathway was involved in longevity and related molecular mechanisms 45 . Together these studies indicated that threonine or its metabolites 8 may affect organismal health-and life-span.

Impairing threonine catabolism has been reported to promote the healthspan of C. elegans. This study concentrated on investigating the action of 10 glycine C-acetyltransferase (GCAT), which is involved in the conversion of the intermediate 2-amino-3-ketobutyrate to glycine and its impairment 11 resulting in an increment in MGO-mediated proteohormesis 21 . Here, we focused on threonine contents itself. We investigated the role of threonine 12 and enzymes involved in its metabolism, which directly influence threonine abundance. First, we determined whether threonine could affect C. 13 elegans lifespan or it was only a consequence of longevity. Low-dose threonine enhanced lifespan and healthspan-related parameters with im-14 proved antioxidative enzyme activities. Because DR-mediated longevity has been correlated with reduced protein and amino acid intake, these 15 effects raise an intriguing question about how certain amino acids have the potential to promote healthspan. Although many of studies have reported 16 the benefits of amino acid restriction, recent research has provided clues about the longevity advantages of specific amino acids in many organisms.

Supplementation of the single amino acid glycine extended lifespan of C. elegans 7 , Drosophila 46 , and mice 6 by attenuation of the progression of 18 dystrophic pathologies. In addition, branched-chain amino acids, a group of essential amino acids, such as leucine, isoleucine, and valine, could 19 impact health and lifespan by affecting amino acid balance 8, 9, 47 . Incited by these findings, we investigated the merits of threonine on fitness and 20 lifespan. Based on published RNA-seq data, the threonine synthesis enzyme, R102.4, was shown to be upregulated in DR-related mutant eat-21 2(ad465) worms and TDH/F08F3.4 was identified amongst the DEGs in the long-lived mutants, daf-2(e1370) and eat-2(ad465) 7,48 . Both threonine 22 synthesis using glycine and homoserine and inhibition of the threonine catabolic enzyme TDH increase threonine contents in DR-mediated long-23 lived worms. 24 We showed that threonine upregulates ferritin, FTN-1, expression. Although the total amount of ferritin protein is increased, the iron storage 25 capacity of ferritin is compromised with age and ablated with senescence 33,49 . We assumed that threonine increases healthspan by attenuating age-26 related ferroptosis. Increasing threonine levels upregulates FTN-1 renewal through a mechanism involving the transcription factors DAF-16 and 27 HSF-1, subsequently reduces the hallmarks of ferroptosis, the redox-active iron level. and blocks the generation of. Moreover, we detected ferrop-28 tosis-related factors, age-pigment lipofuscin accumulation and highly reactive aminoacetone, a precursor of MGO, found to induce dose-dependent 29 ferrous iron release from ferritin 50 decreased in threonine-associated longevity.

According to chromatin immunoprecipitation sequencing (ChIP-seq) results, it has been reported that human ferritin, ferritin heavy chain 1 (FTH-31 1), expression is initiated by the activation of the human homolog of DAF-16, FoxO3 51 . This indicated that ferritin expression might also be 32 regulated by threonine modulation in humans through the activation of the FoxO3 transcription factor. Ferritin imbalance provokes diverse health 33 9 disorders and diseases, such as iron-deficiency anaemia, hypothyroidism, celiac disease in case of deficiency, adult-onset Still's diseases, porphyria, 1 and an acute inflammatory reaction in some cases of COVID-19 52 53 . These observations and manifestations associated with ferritin homeostasis 2 and its turnover are crucial factors to human health and organismal energy balance 54 . So far most of the positive effects of threonine are linked to 3 enhanced immunity, through mucus formation 18,42 , and stimulation of pluripotency of embryonic stem cells [12] [13] [14] [15] . Here, we propose another angle 4 how threonine can achieve health-and lifespan benefits in C. elegans through the attenuation of cellular ferroptosis. Our work should further 5 additional studies to evaluate whether these effects on fitness and longevity translate to mammals and humans. Any method, additional references, extended data, supplemental information can be found with this article online. RNAi, **p < 0.01 and ***p < 0.001 versus the ftn-1 RNAi, n = 3 worm pellets). j, Relative Amplex Red fluorescence in supernatant of worms (#p 23 < 0.001 compared to control RNAi, *p < 0.05 and **p < 0.01 versus ftn-1 RNAi, n = 3 worm pellets). k, Total glutathione (GSH) level was 24 normalized to the GSH level in worms exposed to tdh/F08F3.4 RNAi or threonine (#p < 0.001 compared to control RNAi, *p < 0.05 and **p < values or between two groups were determined using two-tailed t-tests (95% confidence interval). Error bars represent the mean ± s.d. tended Data Table 1 . (FUDR, Sigma-Aldrich, MO, USA) to prevent progeny production. All compounds were blended into the NGM media after autoclaving and before 23 solidification. Living worms were transferred to assay plates, which were seeded with OP50 or a designated RNAi feeding clone with 50 μg ml -1 24 ampicillin (Sigma-Aldrich, MO, USA) every other day. Worms that crawled of the plates or exhibited internal progeny hatching were censored 25 and showed no reaction to gentle stimulation were scored as dead. Lifespan data were analyzed using R software (ver. 4.1.0, "coin" package);

Kaplan-Meire survival curves were depicted and P values were calculated using the log-rank (Mantel-Cox) test. All lifespan data are described in 27 Extended Data Table 1 . triglycerides. TG contents were normalized relative to protein contents and three independently collected worm pellets were assayed for each 1 experimental condition. was determined using standard curves followed by normalization to protein concentration using the BCA protein assay (Pierce, IL, USA). on the day of the assay. For the thermotolerance assay, 18-28 worms were exposed 35°C for 16 hours and survival worms were counted. Assays 13 performed triplicate and survival rate was estimated. Pharyngeal pumping rates of C.elegans 5 The pharyngeal pumping of 30 worms per each condition were assessed for 1 min using a SZ61 microscope (Olympus, Tokyo, Japan). Pharyngeal 6 contractions were recorded with Olympus camera eXcope T300 at 18-fold optical zoom and videos were played back at 0.5× speed and pharyngeal 7 pumps counted. samples with high RNA integrity number scores were proceed to sequencing. For library preparation an amount of 2 mg of total RNA per sample Ion contents were measured using the Iron assay kit (Sigma-Aldrich, MO, USA) with manufacturer's protocol. Briefly, frozen worm pellets in 16 liquid nitrogen with 5% Triton X-100. The pellets were sonicated with 5 volumes of iron assay buffer and centrifuged at 13,000 g for 10 min at 17 4°C to remove insoluble material. Released iron by acidic buffer is reacted with a chromagen resulting in a colorimetric (593 nm) product, pro-18 portion to the iron present. Ferrous/Ferric iron was determined using standard curves followed by normalization to protein concentration using the 19 BCA protein assay (Pierce, IL, USA). Three biological replicates of the assay were performed. 

Quantification of Glutathione in Caenorhabditis elegans

Selection and validation of a set of reliable 4 reference genes for quantitative sod gene expression analysis in C. elegans

STAR: ultrafast universal RNA-seq aligner

Trimmomatic: a flexible trimmer for Illumina sequence data

StringTie enables improved reconstruction of a transcriptome from RNA-seq reads

Transcript-level expression analysis of RNA-seq experiments with 13

OrthoList 2: A New Comparative Genomic Analysis of Human